Strategies of temozolomide in future glioblastoma treatment

References

• StuppRMasonWPvan den BentMJEuropean Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy GroupsNational Cancer Institute of Canada Clinical Trials GroupRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
   PubMed Web of Science ®Google Scholar
• ZhangHGaoSTemozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitroInt J Pharm20073291–212212817000068
   PubMedGoogle Scholar
• TianXHLinXNWeiFEnhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticlesInt J Nanomedicine2011644545221445277
   PubMed Web of Science ®Google Scholar
• JainDSAthawaleRBBajajANUnraveling the cytotoxic potential of temozolomide loaded into PLGA nanoparticlesDaru20142211824410831
   PubMedGoogle Scholar
• LingYWeiKZouFZhongSTemozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant gliomaInt J Pharm20124301–226627522486964
   PubMedGoogle Scholar
• FangCWangKStephenZRTemozolomide nanoparticles for targeted glioblastoma therapyACS Appl Mater Interfaces20157126674668225751368
   PubMed Web of Science ®Google Scholar
• CalinGACroceCMMicroRNA signatures in human cancersNat Rev Cancer200661185786617060945
   PubMed Web of Science ®Google Scholar
• ZhangJHanLGeYmiR-221/222 promote malignant progression of glioma through activation of the Akt pathwayInt J Oncol201036491392020198336
   PubMed Web of Science ®Google Scholar
• ChenLZhangJHanLDownregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 statusOncol Rep201227385486022075712
   PubMedGoogle Scholar
• BertucciAPrasetyantoEASeptiadiDCombined delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cellsSmall201511425687569526395266
   PubMed Web of Science ®Google Scholar
• BernalGMLaRiviereMJMansourNConvection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant gliomaNanomedicine201410114915723891990
   PubMed Web of Science ®Google Scholar
• HuJWangJWangGYaoZDangXPharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cellsInt J Mol Med201637369070226782731
   PubMed Web of Science ®Google Scholar
• SwaminathanSCavalliRTrottaFCyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics developmentWiley Interdiscip Rev Nanomed Nanobiotechnol20168457960126800431
   PubMedGoogle Scholar
• JainDGursalkarTBajajANanosponges of an anticancer agent for potential treatment of brain tumorsAm J Neuroprot Neuroregen2013513243
   Google Scholar
• MaPLBuschmannMDWinnikFMOne-step analysis of DNA/chitosan complexes by field-flow fractionation reveals particle size and free chitosan contentBiomacromolecules201011354955420158194
   PubMed Web of Science ®Google Scholar
• ChaeSYJinCHShinHJYounYSLeeSLeeKCPreparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral deliveryBioconjug Chem200819133434118078308
   PubMed Web of Science ®Google Scholar
• JhaveriNAgasseFArmstrongDA novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cellsCancer Lett2016371224025026683773
   PubMedGoogle Scholar
• ParkMSongCYoonHChoiKHDouble blockade of glioma cell proliferation and migration by temozolomide conjugated with NPPB, a chloride channel blockerACS Chem Neurosci20167327528526711895
   PubMed Web of Science ®Google Scholar
• YoshidaSTsutsumiSMuhlebachGMolecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysisProc Natl Acad Sci U S A201311017E1604E161223564345
   PubMed Web of Science ®Google Scholar
• ConstantinoEMaddalenaFCaliseSTRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptosis in human colorectal carcinoma cellsCancer Lett20092791394619217207
   PubMedGoogle Scholar
• WuJLiuYChoKDownregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogrammingNeuroreport201627313614426716385
   PubMed Web of Science ®Google Scholar
• WangCAbeggDHochDGAdibekianAChemoproteomics-enabled discovery of a potent and selective inhibitor of the DNA repair protein MGMTAngew Chem Int Ed Engl20165582911291526798972
   PubMedGoogle Scholar
• MaiuriMCKroemerGAutophagy in stress and diseaseCell Death Differ201522336536625661524
   PubMedGoogle Scholar
• HuangXBaiHMChenLLiBLuYCReduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumorsJ Clin Neurosci201017121515151920863706
   PubMed Web of Science ®Google Scholar
• NoackJChoiJRichterKKopp-SchneiderARégnier-VigourouxAA sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagyCell Death Dis20145e142525255218
   PubMedGoogle Scholar
• KanzawaTGermanoIMKomataTItoHKondoYKondoSRole of autophagy in temozolomide-induced cytotoxicity for malignant glioma cellsCell Death Differ200411444845714713959
   PubMed Web of Science ®Google Scholar
• ShenXKanSHuJEMC6/TMEM93 suppresses glioblastoma proliferation by modulating autophagyCell Death Dis20167e204326775697
   PubMedGoogle Scholar
• TsaiHCWeiKCTsaiCNEffect of valproic acid on the outcome of glioblastoma multiformeBr J Neurosurg201226334735422168970
   PubMed Web of Science ®Google Scholar
• LeeCYLaiHYChiuAChanSHHsiaoLPLeeSTThe effects of antiepileptic drugs on the growth of glioblastoma cell linesJ Neurooncol2016127344545326758059
   PubMed Web of Science ®Google Scholar
• LuthraPMLalNProspective of cucurmin, a pleiotropic signallling molecule from Cucurma longa in the treatment of GlioblastomaEur J Med Chem2016109233526748069
   PubMed Web of Science ®Google Scholar
• PurkayasthaSBerlinerAFernandoSSCucurmin blocks brain tumor formationBrain Res2009126613013819368804
   PubMed Web of Science ®Google Scholar
• AokiHTakadaYKondoSSawayaRAggarwalBBKondoYEvidence that cucurmin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathwaysMol Pharmacol2007721293917395690
   PubMed Web of Science ®Google Scholar
• ZhuangWLongLZhengBCucurmin promotes differentiation of glioma-initiating cells by inducing autophagyCancer Sci2012103468469022192169
   PubMed Web of Science ®Google Scholar
• PerryMCDemeuleMRéginaAMoumdjianRBéliveauRCucurmin inhibits tumor growth and angiogenesis in glioblastoma xenograftsMol Nutr Food Res20105481192120120087857
   PubMed Web of Science ®Google Scholar
• ZhangICuiYAmiriADingYCampbellREMaysingerDPharmacological inhibition of lipid droplet formation enhances the effectiveness of cucurmin in glioblastomaEur J Pharm Biopharm2016100667626763536
   PubMed Web of Science ®Google Scholar
• SchlegelJMerdesAStummGAmplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastomaInt J Cancer199456172778262681
   PubMed Web of Science ®Google Scholar
• RamosTCFigueredoJCatalaMTreatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: report from a phase I/II trialCancer Biol Ther20065437537916575203
   PubMed Web of Science ®Google Scholar
• SolomónMTSelvaJCFigueredoJRadiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trialBMC Cancer20131329923782513
   PubMed Web of Science ®Google Scholar
• NittaYShimizuSShishido-HaraYSuzukiKShiokawaYNaganeMNimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivoCancer Med20165348649926778701
   PubMed Web of Science ®Google Scholar
• NaritaYBevacizumab for glioblastomaTher Clin Risk Manag2015111759176526664126
   PubMed Web of Science ®Google Scholar
• CaragliaMBudillonATagliaferriPMarraMAbbruzzeseACaponigroFIsoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implicationsCurr Drug Targets20056330132315857290
   PubMed Web of Science ®Google Scholar
• PorruMZappavignaSSalzanoGMedical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidOncotarget2014521104461045925431953
   PubMedGoogle Scholar